DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Torrent Pharmaceuticals Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·10 Sept 2026, 4:01 pm

Torrent Pharmaceuticals L

Torrent Pharmaceuticals Limited has informed the stock exchanges about its upcoming meeting with analysts and institutional investors. This communication serves as a formal disclosure regarding the company's schedule to engage with the financial community.

For investors, such meetings are a key opportunity to gain direct insights into the company's strategic direction and future outlook. Management typically uses these sessions to discuss performance metrics, product pipelines, and market conditions, which can help refine investment thesis.

Investors should watch for any updates on key growth drivers, regulatory approvals, or guidance provided during the session. This information is crucial for making informed decisions about the stock.